To promote patient-led research, ImYoo is launching working groups for people with autoimmune disorders. We are creating communities of patients, advocates, and clinicians who are all working together on designing immune studies!
We’re currently in the brainstorming phase, so if you or someone you care for has one of the conditions listed below, sign up for our Newsletter.
Once our working groups brainstorm the perfect research idea, you may have a chance to participate in that immune study. We’re committed to accessible research, so you will be able to participate from home.
Rheumatoid arthritis (RA)
Rheumatoid arthritis (RA) is characterized by flare ups, which can be unpredictable. However, efforts in RNA-sequencing are already predicting flares with accuracy of up to 2 weeks before the episode.
In the RA Working Group, we ask, "How are these flares triggered?" and "Why do biologics only work for some people?"
Help us crowdsource our first study by supporting and potentially joining as a research participant.
Although Long COVID (LC) is poorly understood by the medical community, we see that research using RNA profiles can fill the gaps.
Members of the LC Working Group want to identify their symptoms and determine whether they're improving or at-risk of relapsing. Help us investigate the LC questions that matter most to you.
We see a lot of immunological questions worth investigating in Long COVID, such as the development of tests for Long COVID and monitoring of immune state to avoid flare ups.
As we prepare an LC study, we invite you to sign up for our Newsletter. You'll be the first to know about our LC brainstorming session!
Inflammatory bowel disease (IBD)
Inflammatory bowel disease (IBD) encompasses ulcerative colitis and Crohn's disease, which single-cell RNA data are already helping us distinguish at high resolution.
The IBD Working Group wants to further the research, but we need your input. Sign up for our Newsletter, and you'll find out when the next ImYoo IBD Forum takes place.